Endocrinology - 3: Preventing complications of diabetes

被引:51
作者
Bate, KL [1 ]
Jerums, G [1 ]
机构
[1] Austin Hlth, Endocrinol Unit, Heidelberg, Vic 3084, Australia
关键词
D O I
10.5694/j.1326-5377.2003.tb05655.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes complications are common and almost triple the annual cost of managing diabetes. Microvascular complications are the major risk in type 1 diabetes, while macrovascular complications are the major cause of morbidity and mortality in type 2 diabetes. Control of hyperglycaemia (target HbA(1c) level less than or equal to 7%) and hypertension (target blood pressure less than or equal to 130/80 mmHg) prevents microvascular complications in both types of diabetes; a multifactorial approach, comprising behaviour modification and pharmacological therapy for all risk factors, reduces the development of micro- and macrovascular complications in type 2 diabetes. The benefit of treating dyslipidaemia is at least as great in the diabetic population as in the non-diabetic population. Angiotensin-converting enzyme inhibitors and low-dose aspirin are indicated in people with diabetes and other cardiovascular risk factors. Regular annual screening for diabetes complications allows treatable disease to be identified.
引用
收藏
页码:498 / 503
页数:6
相关论文
共 31 条
[1]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[2]  
Clark N, 2003, DIABETES CARE, V26, P3333
[3]  
Colagiuri S, 2002, DIABCOST AUSTR ASSES
[4]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[5]   The rising prevalence of diabetes and impaired glucose tolerance - The Australian diabetes, obesity and lifestyle study [J].
Dunstan, DW ;
Zimmet, PZ ;
Welborn, TA ;
de Courten, MP ;
Cameron, AJ ;
Sicree, RA ;
Dwyer, T ;
Colagiuri, S ;
Jolley, D ;
Knuiman, M ;
Atkins, R ;
Shaw, JE .
DIABETES CARE, 2002, 25 (05) :829-834
[6]   Diabetic retinopathy [J].
Fong, DS ;
Cavallerano, JD ;
Aiello, L ;
Ferris, FL ;
Gardner, TW ;
Klein, R ;
King, GL ;
Blankenship, G .
DIABETES CARE, 2003, 26 (01) :226-229
[7]   Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J].
Gaede, P ;
Vedel, P ;
Larsen, N ;
Jensen, GVH ;
Parving, H ;
Pedersen, O .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :383-393
[8]  
Gerstein HC, 2000, LANCET, V355, P253
[9]   The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes [J].
Gilbertson, HR ;
Brand-Miller, JC ;
Thorburn, AW ;
Evans, S ;
Chondros, P ;
Werther, GA .
DIABETES CARE, 2001, 24 (07) :1137-1143
[10]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762